Suppr超能文献

在大鼠中,通过联合使用5-羟色胺2(5-HT2)受体阻断剂利坦色林对多巴胺D2受体拮抗剂雷氯必利进行额外治疗,增强其抗精神病样特性。

Enhancement of antipsychotic-like properties of the dopamine D2 receptor antagonist, raclopride, by the additional treatment with the 5-HT2 receptor blocking agent, ritanserin, in the rat.

作者信息

Wadenberg M L, Salmi P, Jimenez P, Svensson T, Ahlenius S

机构信息

Department of Behavioral and Biochemical Pharmacology, Astra Arcus AB, Södertälje, Sweden.

出版信息

Eur Neuropsychopharmacol. 1996 Nov;6(4):305-10. doi: 10.1016/s0924-977x(96)00035-1.

Abstract

The effects of 5-HT2 receptor blockade on the ability of a dopamine (DA) D2 receptor antagonist to produce suppression of conditioned avoidance response (CAR) and to produce catalepsy in rats were examined. It was found that ritanserin (2 mg kg-1 s.c.) enhanced the raclopride (0.1 mg kg-1 s.c.)-induced suppression of CAR without affecting raclopride-induced catalepsy at either maximal (4 mg kg-1 s.c.) or submaximal (0.2 mg kg-1 s.c.) doses. Considering the CAR performance as an index of mesocorticolimbic dopaminergic functions, it is concluded that 5-HT2 receptor blockade confers a limbic profile on the DA D2 receptor antagonist.

摘要

研究了5-羟色胺2(5-HT2)受体阻断对多巴胺(DA)D2受体拮抗剂抑制大鼠条件性回避反应(CAR)及产生僵住症能力的影响。结果发现,利坦色林(2毫克/千克,皮下注射)增强了雷氯必利(0.1毫克/千克,皮下注射)诱导的CAR抑制作用,且在最大剂量(4毫克/千克,皮下注射)或次最大剂量(0.2毫克/千克,皮下注射)时均不影响雷氯必利诱导的僵住症。将CAR表现作为中脑皮质边缘多巴胺能功能的指标,得出结论:5-HT2受体阻断使DA D2受体拮抗剂具有边缘系统特征。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验